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Tumor necrosis factor (TNF) is a pro-inflammatory cytokine with multiple biological 
effects. The receptors for this cytokine on neutrophils have been shown to be rapidly 
down-regulated following activation, leading to the release of soluble forms of these 
receptors. Thus neutrophils become less responsive to TNF and the soluble TNF 
receptors (TNFR) serve to control TNF activity. During inflammation, leukocytes 
become activated as a result of the action of a variety of mediators. These mediators 
include not only cytokines but also lipids, such as the pro-inflammatory 00-6 fatty acid, 
arachidonic acid (AA) and its metabolites. Cellular activation leads to the release of 
AA from membrane phospholipids. AA regulates the function of many cell types 
including neutrophils. In view of the known pro-inflammatory properties of AA and 
the anti-inflammatory properties of 00-3 fatty acids, a study was undertaken to 
examine whether or not these fatty acids regulate the expression and release of TNFR 
in neutrophils. 
While much emphasis has been placed on agonist-induced down-regulation of TNFR, 
our data show that AA causes a rapid (10-20 min) and dose-dependent (0.5 to 30 I-LM) 
increase (8-fold) in the surface expression of both classes of TNFR (TNFRl and 
TNFRlI) on human neutrophils, at concentrations found in inflammatory fluids. This 
correlates with an increase in superoxide production to a TNF challenge. In contrast, 
both fMLP and LPS significantly reduce the expression of both TNF receptors. 
Interestingly, in neutrophils pretreated with AA, fMLP causes an increase in TNF 
receptor expression, consistent with AA preventing the fMLP-induced receptor release 
in neutrophil culture. In addition, while AA causes an increase in TNF receptor 
expreSSIOn on matured HL-60 cells (neutrophil-like cells), a decrease occurs on 
HUVEC and non-matured HL-60 cells. These data demonstrate a unique effect of AA 
on neutrophils. 
The relationship between AA and the anti-inflammatory (0-3 fatty acids, DHA and 
eicosapentaenoic acid (EPA), in the modulation of TNF receptor expression has also 
been examined. These (0-3 polyunsaturated fatty acids, including linolenic acid 
(LNA), cause a decrease in TNFR expression on neutrophils. The (0-6 linoleic acid 
(LA) and (0-9 oleic acid (OA) both cause an increase in TNFR expression. 
Furthermore, pre-exposure of neutrophils to nanomolar amounts of EPA or DHA 
prevents the AA-induced up-regulation of TNFR. These results thus identify another 
mechanism of regulating the inflammatory reaction by the (0-3 fatty acids. 
The mechanisms by which AA induces an increase in TNFR expression have been 
studied. Masking of the carboxyl group results in loss of activity. It is unlikely that a 
product of AA is responsible since neither the hydroperoxyeicosatetraenoic acid, nor 
hydroxyeicosatetraenoic acid derivatives show activity. Also, the effects of AA are 
not sensitive to the action of inhibitors of the cyc100xygenases and lipoxygenases. 
U sing chemical inhibitors of intracellular signaling pathways, we demonstrate that the 
effect of AA on TNFRI is very sensitive to GFI09203X, PD098059, AACOCF3 and 
wortmannin, showing a role for protein kinase C, the extracellular signal regulated 
protein kinases and cytoplasmic phospholipase A2, and PI-3 kinase respectively, in 
the enhancement of TNF receptor expression by AA. Although the effects of AA on 
TNFRII are also decreased by the chemical inhibitors, the results show that these 
signalling molecules only contribute in part to the mechanisms of increased TNFRII 
receptor expression. 
The data presented in this thesis suggest a novel role for AA in the inflammatory 
reaction, through its action on neutrophil TNFR expression. The work has identified a 
unique effect of 00-3 polyunsaturated fatty acids for regUlating this AA-induced 
increase in the expression of TNF receptors. 
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